The Food and Drug Administration (FDA) was dangerously slow to respond to multiple complaints about conditions at an Abbott Nutrition facility that contributed to a nationwide infant formula shortage in 2022, according to a government watchdog report.
FDA did not have adequate — and in some cases completely lacked — policies and procedures to identify risks to infant formula and then respond to those risks effectively, the report from the Department of Health and Human Services’ Office of Inspector General (OIG) found.
For instance, the agency took more than 15 months…
